Please use this identifier to cite or link to this item:
Title: The management of patients positive to hepatitis C virus antibody in Malta
Authors: Brincat, Anthea
Azzopardi, Neville
Deguara, Maria
Mifsud Taliana, Kelly
Rogers, Marilyn
Pocock, James
Keywords: Hepatitis C -- Disease management
Hepatitis C -- Patients
Hepatitis C -- Malta -- Statistics
Issue Date: 2013
Publisher: Malta Medical Journal
Citation: Malta Medical Journal. 2013, Vol.25(4), p. 72-77
Abstract: Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease and hepatocellular carcinoma worldwide and is an important public health concern. A retrospective analysis of the demographics and management of patients who had a positive anti-HCV detected by enzyme immunoassay test done at Mater Dei Hospital was carried out to analyse the epidemiology of HCV infection in Malta and assess our management when compared to the European Association for the Study of the Liver (EASL) guidelines. 72% of patients were male. The majority of patients were aged 21-50 years. The main mode of infection was via intravenous drugs use, accounting for 68% of cases. Only 56% of patients found to be HCV Ab positive had a scheduled appointment with an infectious diseases specialist or gastroenterologist documented on the MDH online appointment system. 58% of patients had HCV RNA testing done and 45% had genotype testing. 7.3% with HCV infection were given treatment, of which 43% had a Sustained Virological Response (SVR).
Appears in Collections:MMJ, Volume 25, Issue 4
MMJ, Volume 25, Issue 4
Scholarly Works - FacM&SMed

Files in This Item:
File Description SizeFormat 
2013.Vol25.Issue4.A11.pdfThe management of patients positive to hepatitis C virus antibody in Malta493.77 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.